Finally, GBM cells adapt their migration even in response to anti-angiogenic treatment, by shifting towards perivascular glioma cell invasion, with phosphorylation and upregulation of Met receptor tyrosine kinase induced by VEGF ablation [110,111,112,113,114]. The gene discussed is VEGFA; the disease is glioma.